How should China develop its biopharmaceutical innovation capability?
By: by Wenao Wang
Series: Second year paper
Publisher: John F. Kennedy School of Government
Published: 2012
Place of publication: Cambridge, Mass
Language: eng
Notes: Client: State Council of China.

Advisor: Dani Rodrik.

Section leader: Michael Walton.

Includes bibliographical references.